Krishna Institute of Medical Sciences Limited

NSE:KIMS.NS

673.75 (INR) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42018 Q22018 Q1
Revenue 7,9697,7247,7736,8846,337.976,058.366,524.826,060.295,759.295,621.625,640.724,955.143,524.923,935.684,117.44,731.793,585.383,606.654,096.332,011.012,662.691,642.6451,642.645
Cost of Revenue 3,0121,6181,5553,0022,891.562,651.942,786.832,661.732,492.832,439.962,094.512,224.951,207.361,432.21,490.21,848.552,415.391,341.821,515.89896.761,990.19755.915755.915
Gross Profit 4,9576,1066,2183,8823,446.413,406.423,737.993,398.563,266.463,181.663,546.212,730.192,317.562,503.482,627.22,883.241,169.992,264.832,580.441,114.25672.5886.73886.73
Gross Profit Ratio 0.6220.7910.80.5640.5440.5620.5730.5610.5670.5660.6290.5510.6570.6360.6380.6090.3260.6280.630.5540.2530.540.54
Reseach & Development Expenses 00000000000000000000000
General & Administrative Expenses 0000243.160001,791.0700093.5000251.1700017.71492.145492.145
Selling & Marketing Expenses 0000251.59000197.39000111.5100032.2400028.916.41516.415
SG&A 0002,4782,319.712,288.972,291.342,150.571,988.462,002.7601,652.731,187.89000283.410-1,248.46046.61508.56508.56
Other Expenses 04,6814,4470032.5528.8231.1248.8303,546.21002,503.482,627.22,883.2402,264.832,580.441,114.25000
Operating Expenses 04,6814,447-3902,319.712,288.975,1213,7211,988.463,514.583,546.213,024.361,195.562,503.482,627.22,883.242,248.452,264.831,331.981,114.2546.61670.575670.575
Operating Income 4,9571,4251,7711,4041,126.71,148.771,475.251,2481,326.861,178.91,213.131,077.461,129.971,109.531,106.391,265.8917.31735.71,248.46187.75464.22378.17378.17
Operating Income Ratio 0.6220.1840.2280.2040.1780.190.2260.2060.230.210.2150.2170.3210.2820.2690.2680.2560.2040.3050.0930.1740.230.23
Total Other Income Expenses Net -3,617-79-149-133-126.76-123.77-89.1-62.21-54.15-50.73161.53-3.91-61.7913.9325.19-20.49-107.11-90.52-53.75-47.69-89.22-234.81-234.81
Income Before Tax 1,3401,3461,6221,271999.941,0251,386.151,185.791,272.711,128.171,374.661,073.551,068.181,123.461,131.581,245.31810.2645.181,194.71140.06375143.36143.36
Income Before Tax Ratio 0.1680.1740.2090.1850.1580.1690.2120.1960.2210.2010.2440.2170.3030.2850.2750.2630.2260.1790.2920.070.1410.0870.087
Income Tax Expense 279421415319285.02258.99373.21319.08285.96309.9313.98281.1234.94281.59289.04325.01223.99167.39293.1650.8297.650.08550.085
Net Income 1,0188871,074866654.73718.44920.16808932.72759.8971.14699.58806.88811.75817.17891.05578.02487.91834.75111.27286.5289.04589.045
Net Income Ratio 0.1280.1150.1380.1260.1030.1190.1410.1330.1620.1350.1720.1410.2290.2060.1980.1880.1610.1350.2040.0550.1080.0540.054
EPS 2.542.222.682.161.641.82.32.022.331.92.431.751.782.032.072.31.521.312.20.290.760.250.25
EPS Diluted 2.542.222.682.161.641.82.32.022.331.92.431.751.782.032.072.31.491.292.150.290.760.250.25
EBITDA 1,9622,0502,2311,8401,627.771,5031,801.541,601.761,681.171,576.331,764.651,424.981,292.021,341.191,341.851,479.411,018.84931.161,427.8400.86615.54312.695312.695
EBITDA Ratio 0.2460.2650.2870.2670.2570.2480.2760.2640.2920.280.3130.2880.3670.3410.3260.3130.2840.2580.3490.1990.2310.190.19